From the Food and Drug Administration.
| Autor: | Henney, Jane E., Henney, J E |
|---|---|
| Předmět: |
HYPERPLASIA treatment
CHRONIC pain CORONARY heart disease prevention MYOCARDIAL infarction ACE inhibitors CARDIOVASCULAR disease prevention FOOT diseases ANTIHYPERTENSIVE agents FASCIITIS PAIN management BENIGN prostatic hyperplasia RAMIPRIL DRUG side effects MICROWAVES PAIN ULTRASONIC therapy ULTRASONICS HEEL (Anatomy) THERAPEUTICS |
| Zdroj: | JAMA: Journal of the American Medical Association; 12/6/2000, Vol. 284 Issue 21, p2711-2711, 1p |
| Abstrakt: | Presents medical news briefs from the United States Food and Drug Administration. Warning of complications associated with the use of microwave energy to treat benign prostatic hyperplasia; Approval of the OssaTron, a device which delivers acoustic shock waves for the treatment of chronic proximal plantar fascitis; Approval of the use of the hypertensive drug ramipril to reduce the risk of myocardial infarction and stroke; Others. |
| Databáze: | Complementary Index |
| Externí odkaz: |
|